Ipamorelin 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Ipamorelin supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF082025023

Key analytical results include:

• Assay Content: 9.99 mg
• Identification – Retention Time: 0.999
• Identification – Spectrum: 997
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: detected but below 0.01 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Ipamorelin is a synthetic pentapeptide research compound frequently studied in controlled laboratory environments investigating peptide-mediated signalling pathways and receptor interaction mechanisms.

The compound belongs to a class of growth hormone secretagogue peptides examined for their interaction with ghrelin receptors and related endocrine signalling systems.

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, Ipamorelin has become a widely referenced compound in experimental models studying peptide receptor signalling and endocrine regulatory mechanisms.

Compound Overview

Ipamorelin is a synthetic pentapeptide originally developed in research exploring growth hormone secretagogue receptor (GHS-R) interaction.

The compound is structurally related to ghrelin receptor agonist peptides and has been examined in laboratory models investigating receptor-mediated signalling pathways.

In biochemical research environments, Ipamorelin is studied for its interaction with ghrelin receptor systems involved in endocrine signalling and metabolic regulatory pathways.

These receptor-mediated pathways influence complex biochemical communication systems involved in intracellular signalling and regulatory processes.

Historical Background and Scientific Context

Scientific interest in growth hormone secretagogue peptides expanded during the late twentieth century as researchers began investigating peptide compounds capable of interacting with endocrine signalling systems.

During the 1990s and early 2000s several synthetic peptides were developed to study receptor-mediated signalling pathways related to ghrelin and growth hormone regulatory systems.

Ipamorelin emerged as one of the research peptides examined for its selective interaction with ghrelin receptor pathways under controlled laboratory conditions.

Since its introduction in experimental peptide research, the compound has been used in multiple biochemical models studying peptide signalling networks and receptor-mediated regulatory systems.

Mechanistic Focus in Research

Within experimental laboratory environments, Ipamorelin is frequently studied in relation to peptide-receptor interaction pathways and endocrine signalling networks.

Research investigations commonly explore the compound in experimental models examining:

• Growth hormone secretagogue receptor interaction
• Ghrelin receptor signalling pathways
• Peptide-mediated endocrine signalling systems
• Intracellular peptide signalling networks
• Comparative peptide receptor interaction studies
• Endocrine regulatory pathway modelling
• Cellular signalling communication systems

These experimental models allow scientists to investigate molecular signalling mechanisms that influence peptide-mediated biochemical processes.

Research Applications

In controlled research environments, Ipamorelin may be utilised in experimental models designed to explore peptide receptor signalling and endocrine regulatory pathways.

Examples of research applications include:

• Peptide signalling pathway investigation
• Ghrelin receptor interaction studies
• Endocrine signalling analysis
• Comparative peptide compound evaluation
• Intracellular regulatory pathway modelling
• Peptide-receptor biochemical research
• Controlled in vitro endocrine studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Above 99.8 percent purity with validated assay content
• Endotoxin detected but below 0.01 EU per mg
• No detectable heavy metals or microbial contamination
• Batch GF082025023 – Published September 2025
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.